Susan Wyllie

Dual Action of Antimonial Drugs on Thiol Redox Metabolism in the Human Pathogen Leishmania donovani

Susan Wyllie, Mark L. Cunningham, Alan H. Fairlamb · Journal of Biological Chemistry · 2004 · 310 citations · Full text

Life Sciences, Biochemistry, Pharmacology +17

Preclinical candidate for the treatment of visceral leishmaniasis that acts through proteasome inhibition

Susan Wyllie, Stephen Brand, Michael G. Thomas et al. · Proceedings of the National Academy of Sciences · 2019 · 173 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

The Anti-Trypanosome Drug Fexinidazole Shows Potential for Treating Visceral Leishmaniasis

Susan Wyllie, Stephen Patterson, Laste Stojanovski et al. · Science Translational Medicine · 2012 · 170 citations · Full text

Veterinary Medicine, Infectious Diseases, Pharmacology +16

Comparison of a High-Throughput High-Content Intracellular Leishmania donovani Assay with an Axenic Amastigote Assay

Manu De Rycker, Irene Hallyburton, John Thomas et al. · Antimicrobial Agents and Chemotherapy · 2013 · 149 citations · Full text

Veterinary Medicine, Infectious Diseases, Pharmacology +14

Cyclin-dependent kinase 12 is a drug target for visceral leishmaniasis

Susan Wyllie, Michael G. Thomas, Stephen Patterson et al. · Nature · 2018 · 145 citations · Full text

Veterinary Medicine, Medicinal Chemistry, Pharmacology +15